Sanofi invests heavily in multiple myeloma pipeline
The Paris-based Big Pharma has signed a license agreement with Californian biotech Eureka Therapeutics and Memorial Sloan Kettering Cancer Center,...
Spectricity raises €14m in Series B round
Atlantic Bridge, Capricorn Fusion China Fund, Shanghai Semiconductor Equipment and the Material Fund (SSMEF) led the Series B financing round...
Novalis Biotech closes biotech fund at €25m
According to the Belgium-headquartered venture capital specialist, the investor base includes institutional investors, such as Participatie...
Bayer: Peptide deal with Gubra
The partnership utilises Gubra’s machine learning-based peptide drug discovery platform for fast screening and identification of potent therapeutic...
AXA IM Alts raises €1.9bn European Life Sciences Fund
The capital was raised over the last seven months, with commitments to a significantly oversubscribed fund raise from a range of clients from North...
Sanofi snaps up mRNA partner for US$3.2bn
Sanofi got ahead of the rumours on Tuesday, announcing it had agreed to acquire US biotech Translate Bio for US$38 per share. Translate Bio brings...
New vaccine trial targets Covid variants
VLA2001 consists of inactivated whole virus particles of SARS-CoV-2 with high S-protein density, in combination with two adjuvants. It is currently...